OpenVSafe by OpenVAERS
Search V-safe

TA6-19659-25941

3 vaccinations 1 coded response 11 check-ins 1 free-text entry 1 call case
Sex
Female
Age at first dose
46-50
ZIP prefix
322 / FL
Registered
2021-03-31
Relationship
Self
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-31
    Registered in v-safe
  2. 2021-03-31
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-31
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-04-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Redness, Swelling · Headache
    Adult check-in
  5. 2021-04-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Redness, Swelling · Headache
    Adult check-in
  6. 2021-04-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  7. 2021-04-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-04-05
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-04-06
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-04-07
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-04-21
    Dose 2 — Pfizer-BioNTech
  12. 2021-04-28
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-05-07
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-10-20
    Survey response — 6 months, dose 2
    MedDRA: Fatigue — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Extreme tiredness
    MedDRA releases: 2024-11 · check-in free text available
  15. 2021-10-20
    Report sent to call center — 6 months, dose 2
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  16. 2021-10-22
  17. 2022-03-03
    Dose 3 — Pfizer-BioNTech

Vaccinations

DoseDateManufacturerCo-administered
12021-03-31Pfizer-BioNTech
22021-04-21Pfizer-BioNTech
32022-03-03Pfizer-BioNTech No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 10 — 6 months, dose 2

2021-10-20

Symptoms: Extreme tiredness

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDFatigue · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…